Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioventix PLC | AQSE:BVXP.GB | Aquis Stock Exchange | Ordinary Share | GB00B4QVDF07 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,750.00 | 3,650.00 | 3,850.00 | 3,760.8333 | 3,750.00 | 3,750.00 | 214 | 13:10:09 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Nov 2022 to Nov 2024
TIDMBVXP
RNS Number : 4761O
BioVentix PLC
31 January 2023
Bioventix plc
("Bioventix" or the "Company")
Director/PDMR Shareholdings and Issue of Equity
Bioventix plc (BVXP), a UK company specialising in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, announces that the following Directors have dealt in the Company's ordinary shares of 5 pence each (the "Ordinary Shares"):
Hot Features
Premium
Director Role Options Ordinary Sale Ordinary % of issued
over Ordinary Shares price Shares share capital
Shares sold per Ordinary held on held on
exercised Share Admission Admission
Non-Executive
Ian Nicholson Chairman 1,600 1,600 3,750 15,500 0.3%
----------------- --------------- --------- -------------- ----------- ---------------
Chief Executive
Peter Harrison Officer - 57,588 3,750 359,088 6.9%
----------------- --------------- --------- -------------- ----------- ---------------
Nicholas Non-Executive
McCooke Director 2,752 2,752 3,750 - -
----------------- --------------- --------- -------------- ----------- ---------------
The options over Ordinary Shares ("Options") were exercised at a price of 1350 pence per Ordinary Share pursuant to the Company's 2013 EMI Share Option Scheme, details of which can be found at www.bioventix.com . In addition, a current employee exercised 2,000 Options.
Issue of Equity
The Company has applied for 6,352 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur and that dealings will commence in the new Ordinary Shares on 6 February 2023. The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.
The total number of Ordinary Shares in issue following Admission will be 5,215,685 and the Company holds no shares in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company will be 5,215,685.
The above figure of 5,215,685 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Bioventix under the FCA's Disclosure Guidance and Transparency Rules.
For further information please contact:
Bioventix plc Tel: 01252 728 001 Peter Harrison Chief Executive Officer Bruce Hiscock Chief Financial Officer finnCap Ltd Tel: 020 7220 0500 Geoff Nash/Simon Hicks Corporate Finance Alice Lane ECM
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Ian Nicholson
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status Chairman
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Bioventix plc
------------------------------- ----------------------------------
b) LEI 213800225MHX7LZQY108
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
------------------------------- ----------------------------------
b) Nature of the transaction Exercise of Options over Ordinary
Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
1,350p 1,600
----------
------------------------------- ----------------------------------
d) Aggregated information: See 4(c)
* Aggregated volume
* Price
------------------------------- ----------------------------------
e) Date of the transaction 31 January 2023
------------------------------- ----------------------------------
f) Place of the transaction Off market transaction
------------------------------- ----------------------------------
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Ian Nicholson
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status Chairman
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Bioventix plc
------------------------------- ----------------------------------
b) LEI 213800225MHX7LZQY108
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
------------------------------- ----------------------------------
b) Nature of the transaction Sale of Ordinary Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
3,750 1,600
----------
------------------------------- ----------------------------------
d) Aggregated information: See 4(c)
* Aggregated volume
* Price
------------------------------- ----------------------------------
e) Date of the transaction 31 January 2023
------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
(XLON)
------------------------------- ----------------------------------
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Peter Harrison
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status Chief Executive Officer
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Bioventix plc
------------------------------- ----------------------------------
b) LEI 213800225MHX7LZQY108
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
------------------------------- ----------------------------------
b) Nature of the transaction Sale of Ordinary Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
3,750p 57,558
----------
------------------------------- ----------------------------------
d) Aggregated information: See 4(c)
* Aggregated volume
* Price
------------------------------- ----------------------------------
e) Date of the transaction 31 January 2023
------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
(XLON)
------------------------------- ----------------------------------
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Nicholas McCooke
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Bioventix plc
------------------------------- ----------------------------------
b) LEI 213800225MHX7LZQY108
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
------------------------------- ----------------------------------
b) Nature of the transaction Exercise of Options over Ordinary
Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
1,350p 2,752
----------
------------------------------- ----------------------------------
d) Aggregated information:
* Aggregated volume See 4(c)
* Price
------------------------------- ----------------------------------
e) Date of the transaction 31 January 2023
------------------------------- ----------------------------------
f) Place of the transaction Off market transaction
------------------------------- ----------------------------------
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Nicholas McCooke
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Bioventix plc
------------------------------- ----------------------------------
b) LEI 213800225MHX7LZQY108
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 5 pence each
Financial instrument,
type of instrument
Identification code GB00B4QVDF07
------------------------------- ----------------------------------
b) Nature of the transaction Sale of Ordinary Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
3,750p 2,752
----------
------------------------------- ----------------------------------
d) Aggregated information: See 4(c)
* Aggregated volume
* Price
------------------------------- ----------------------------------
e) Date of the transaction 31 January 2023
------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
(XLON)
------------------------------- ----------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAXFFDEEDEFA
(END) Dow Jones Newswires
January 31, 2023 12:03 ET (17:03 GMT)
1 Year Bioventix Chart |
1 Month Bioventix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
